BDC Venture Capital earmarks additional $135 mln for healthcare investing
BDC Venture Capital, the investment arm of the Business Development Bank of Canada, has allocated $135 million in new capital to direct investments in innovative healthcare companies. That brings BDC's total direct commitment to the sector to $270 million. BDC Venture Capital Healthcare Fund will continue to spearhead this activity, investing in Canadian companies in such fields as innovative therapeutics and medical technology, diagnostics, health IT, mobile technologies and services, as well as robotics and automation. Life sciences companies backed by the fund's team include Cytochroma, ViroChem, OncoGeneX, Gemin X and Tekmira.
18 September 2013•3 mins read
